Abstract
Whipple's disease is a multisystemic disorder in which almost all organ systems can be invaded by rod-shaped bacteria. Without extended antimicrobial therapy, its course is lethal. Empirically, treatment consists of tetracyclines given for one to two years. Trimethoprim-sulfamethoxazole, a compound that crosses the blood-brain barrier, has been suggested as an alternative when patients were observed with progressive cerebral involvement. There has never been a formal evaluation of the selection of antibiotics for the treatment of Whipple's disease. In the present nonrandomized, partially retrospective study, we compared the result of two treatment regimens in 30 patients, all examined personally. Twenty-two patients were treated with tetracycline and eight patients with trimethoprim-sulfamethoxazole. In five patients, therapy with tetracycline was changed to another antimicrobial agent because of treatment failure or drug intolerance. The main treatment measure was disappearance of the clinical symptoms such as weight loss, arthritis, malabsorption, fever, edema, central nervous system manifestations, lymphadenopathy, and congestive heart failure. Drug intolerance requiring a change of medication was also considered a treatment failure. We found that trimethoprim-sulfamethoxazole induced complete clinical remission in 12 of 13 treatment cycles, tetracycline in 13 of 22 treatment cycles (P<0.05; mean difference 33%; 95% confidence interval 8% to 58%). Trimethoprim-sulfamethoxazole was also more efficacious than tetracycline in the treatment of cerebral Whipple's disease. However, trimethoprim-sulfamethoxazole did not prevent cerebral manifestations in all cases. The only deaths due to Whipple's disease occurred in patients with cerebral involvement. It is concluded that treatment with trimethoprim-sulfamethoxazole was significantly superior to that with tetracycline in inducing clinical remission of Whipple's disease. A more active antimicrobial regimen is necessary to treat cerebral involvement.
Similar content being viewed by others
References
Relman DA, Schmidt TM, MacDermott RP, Falkow S: Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 327:293–301, 1992
Paulley JW: A case of Whipple's disease (intestinal lipodystrophy). Gastroenterology 22:128–133, 1952
Ruffin JM, Kurtz SM, Roufail WM: Intestinal lipodystrophy (Whipple's disease)—the immediate and prolonged effect of antibiotic therapy. JAMA 195:182–184, 1966
Maizel H, Ruffin JM, Dobbins WO III: Whipple's disease: A review of 19 patients from one hospital and a review of the literature since 1950. Medicine 42:175–205, 1970
Schur P: Psoriatic arthritis and arthritis associated with gastrointestinal diseasesIn Harrison's Principles of Internal Medicine, 12th ed. JD Wilson, E Braunwald, KJ Isselbacher, RG Petersdorf, JB Martin, AS Fauci, RK Root (ed). McGraw-Hill, New York, 1991. pp 1482–1484
Bai JC, Crosetti EE, Maurino EC, Martinez CA, Sambuelli SA, Boerr LA: Short-term antibiotic treatment in Whipple's disease. J Clin Gastroenterol 13:303–307, 1991
Fleming JL, Wiesner RH, Shorter RG: Whipple's disease: Clinical, biochemical and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc 63:539–551, 1988
Keinath RD, Merrell DE, Vliestra R, Dobbins WO III: Antibiotic treatment and relapse in Whipple's disease. Gastroenterology 88:1867–1873, 1985
Knox DL, Bayless TM, Yardley JH, Charache P: Whipple's disease presenting with ocular inflammation and minimal intestinal symptoms. John Hopkins Med J 123:175–181, 1968
Knox DL, Bayless TM, Pittman FE: Neurologic disease in patients with treated Whipple's disease. Medicine 55:467–476, 1976
Feurle GE, Volk B, Waldherr R: Cerebral Whipple's disease with negative jejunal histology. N Engl J Med 300:907–908, 1979
Barling RWA, Selkon JB: The penetration of antibiotics into cerebrospinal fluid and brain tissue. J Antimicrobiol Chemother 4:203–227, 1978
Wang EEL, Prober CG: Ventricular cerebrospinal fluid concentrations of trimethoprim-sulfamethoxazole. J Antimicrobiol Chemother 11:385–389, 1983
Feurle GE: Morbus Whipple. Handbuch der Inneren Medizin Bd. III/3. B. Dünndarm. Berlin, Springer-Verlag, 1983, pp 85–104
Elsborg L, Gravgaard E, Jacobson NO: Treatment of Whipple's disease with sulfamethoxazole-trimethoprim. Acta Med Scand 198:141–143, 1975
Tauris P, Moesner J: Whipple's disease—clinical and histopathological changes during treatment with sulfamethoxazole-trimethoprim. Acta Med Scand 204:423–427, 1978
Viteri AL, Greene JF, Chandler JB: Whipple's disease, successful response to sulfamethoxazole-trimethoprim. Am J Gastroenterol 75:309–310, 1981
Ryser RJ, Locksley RM, Eng SC, Dobbins WO III, Schoenknecht FD, Rubin CE: Reversal of dementia associated with Whipple's disease by trimethoprim-sulfamethoxazole, drugs that penetrate the blood-brain barrier. Gastroenterology 86:745–752, 1984
Krücke W, Stochdorph O: Über Veränderungen im Zentralnervensystem bei Whipple'scher Krankheit. Verh Dtsch Ges Pathol 46:198–202, 1962
Lapointe LR, Lamarche J, Salloum A, Beaudry R: Meningoependymitis in Whipple's disease. J Can Sci Neurol 7:163–167, 1980
Romanul FCA, Radvany J, Rosales RK: Whipple's disease confined to the brain: A case studied clinically and pathologically. J Neurol Neurosurg 40:901–909, 1977
Powers JM, Rawe SE: A neuropathologic study of Whipple's disease. Acta Neuropathol 48:223–226, 1979
Simberkoff MS, Moldover NH, Rahal JJ Jr: Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids: A regional host defense deficiency. J Lab Clin Med 95:362–372, 1980
Martin FF, Vilseck J, Dobbins WO III, Buckley CE, Tyor MP: Immunological alteration in patients with treated Whipple's disease. Gastroenterology 63:6–18, 1972
Feurle GE, Dörken B, Schöpf E, Lenhard V: HLA B27 and defects in the T-cell system in Whipple's disease. Eur J Clin Invest 9:385–389, 1979
Marth T, Feurle GE, Roux M, Meuer SC: Impaired interaction of immunocompetent cells in Whipple's disease. Immunobiology 183:239–240, 1991 (abstract)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Feurle, G.E., Marth, T. An evaluation of antimicrobial treatment for whipple's disease. Digest Dis Sci 39, 1642–1648 (1994). https://doi.org/10.1007/BF02087770
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02087770